24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
Clinical trial NCT01101841 · COMPLETED
Trial details
- NCT number
- NCT01101841
- Sponsor
- Noven Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-09-01
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.